INTRODUCTION
Respiratory syncytial (RS) virus is a major cause of respiratory illness in infants and repeated infections are common (Beem, 1967; Henderson et al., 1979) . Antigenic variation has been observed among isolates of RS virus (Chanock et al., 1957; Coates et al., 1963; Hierholzer & Hirsch, 1979; Wulff et al., 1964) ; however, the differences between isolates appear to be minor. Although human infants show a degree of specificity in their antibody responses (Hendry et al., 1986b) , antigenically distinct strains induce cross-protective immunity in animals (Prince et al., 1985) . It is not clear therefore whether antigenic variation plays a role in re-infection. However, as antigenically distinct strains may vary in other biological properties such as virulence for human infants an analysis of strain variation should facilitate our understanding of the epidemiology and pathogenesis of RS virus infection.
Initially, evidence for heterogeneity among new isolates was sought from cross-neutralization studies using hyperimmune antisera (Coates et al., 1963 (Coates et al., , 1966 and patterns of electrophoretic mobility of specific viral polypeptides (Cash et al., 1977) . Variations in the molecular weight of the phosphoprotein (P) of the virus were shown to correlate with epitopic differences among strains as defined by monoclonal antibodies (MAbs) (Gimenez et al., 1986) . Recently, the use of MAbs directed against several virus polypeptides has led to the recognition of two distinct virus subgroups, A and B, with broad agreement between several laboratories in different parts of the world (Anderson et al., 1985; Mufson et al., 1985) . Differences in P protein size are characteristic for each subgroup (Norrby et al., 1986) . In recent years these two subgroups have co-circulated within the population at least in Europe and America. How long this has been the case and to what degree the two subgroups are stable remains uncertain.
We have looked for evidence of antigenic and structural variation in RS virus isolates collected in Newcastle upon Tyne, U.K. over 20 years. Drawing upon a panel of 17 MAbs 0000-7710 © 1987 SGM directed against the fusion (F), large glycoprotein (G), nucleoprotein (N), P, matrix protein (M) and 22K polypeptide of the virus we have characterized all virus strains with the Western blotting technique by which the presence of individual epitopes and the molecular weights of virus proteins can be determined.
METHODS
Viruses. The Long, A2 and 8/60 strains of RS virus were grown in HeLa cell monolayers in Eagle's minimal essential medium containing 2~ foetal calf serum and antibiotics. Cells and media were harvested when the c.p.e.
was extensive and were frozen at -70 °C. Field strains were isolated from clinical specimens and passaged two or three times in HeLa cell cultures until infectivity titres were similar to those of laboratory strains.
Monoelonal antibodies. Antibodies to the A2 strain of virus were produced in this laboratory (Routledge et al., 1985) or generously made available by Dr E. J. Stott (Taylor et al., 1984) and Professor E. Norrby (Mufson et al., 1985) (Table 1) . MAb 1C2 was produced by a protocol similar to that described previously (Routledge et al., 1985) . Spleen cells from a BALB/c mouse immunized with 2425, a 1984 Newcastle field isolate, were fused with murine myeloma cell line NS-1. After cloning by limiting dilution, hybridoma cells were used for the production of ascites tumours in pristane-primed BALB/c mice. The MAb class was determined using immunoglobulin class-specific antisera (Miles-Yeda) in an ELISA test.
Western blot analyses. Western blot analyses were carried out as described previously (Samson et al., 1986) .
RESULTS
Of 16 MAbs raised against the A2 or Long strains of virus, 12 stained Western blots of HeLa cells infected with the A2 strain of RS virus resolved in polyacrylamide gels run under nonreducing conditions (Table 1) . Several of these also identified bands in Western blots of cells infected with the 8/60 strain of virus indicating that they had reacted with epitopes possessed by both the A (A2) and B (8/60) virus subgroups of Mufson et al. (1985) . Four antibodies, 3F4, 4G4, 3G7 (anti-G) and 1C1 (anti-22K) failed to react with subgroup B but reacted strongly with subgroup A.
A pool of two subgroup-specific MAbs, 3F4 (anti-G) and 1C 1 were tested by Western blotting against a group of eight isolates from Newcastle patients collected between 1965 and 1984. A subgroup cross-reactive anti-P MAb (3H10) was also included in the pool to monitor variations in the position of the P protein. The 1C1 MAb stained two bands in the A2 virus track, 22Ka and 22Kb, of apparent Mr 19000 and 16000 as reported by Routledge et al. (1987) . P protein Mr values were determined on Western blots of gels run under reducing conditions (not shown). Only the 1972 Newcastle isolate 8870 resembled the A2 strain of virus and reacted with all three MAbs. The remainder reacted with only the anti-P MAb 3H10 (Fig. 1 a) and hence resembled the 8/60 strain. This group of putative subgroup B strains however was clearly heterogeneous as staining with MAb 3H10 revealed strain variations in the molecular weight of the P protein, which was either Mr 31000, 33000 or 34000.
In order to investigate further the heterogeneity among putative B subgroup strains, one such strain, 2425 (1984) , was selected as an immunogen to prepare further MAbs. One of the resultant hybridomas, IC2, produced antibody of class IgG 2a which reacted with the G protein of the isolate in Western blots. In addition this MAb reacted faintly with a lower Mr band, of approximately 50000, and also, again faintly, with a higher Mr band in a position corresponding to that of a band stained by 3F4 in A2 strain lysates. Low Mr bands possessing epitopes present on the G protein have previously been described by Routledge et al. (1986) .
The panel of Newcastle isolates and laboratory strains of virus was then re-tested against a MAb pool containing 1C2 (Fig. 1 b) . The anti-P MAb 3H10 was again included in the pool as was a further MAb, 5H5, which reacts with the 22K protein of both A and B virus subgroups. MAb 1C2 stained the G protein of all virus strains possessing a Mr 34000 P protein, including both prototype subgroup A strains and isolates lacking the 3F4 and 1C1 epitopes. The 1C2 nonreactive strains all possessed a lower M r P protein, either M r 31000 or 33000, and also differed from the subgroup A strains in the mobility of the b band of the 22K protein. In svmmary, viruses with four combinations of MAb reactivity and P protein mobility could be distinguished (Table 2) .
A isolates from the 1984 to 1985 epidemic were tested for reactivity with MAbs 3F4, 1C2, 5H5, 1C1 and 3H10 ( Fig. 2 and 3 ). In these gels the P protein of the A2 strain was resolved into two bands, the most intensely stained corresponding to the Mr 34000 band described above and the fainter band running in a similar position to the Mr 33000 P protein present in some of the 1C2 non-reactive strains. In some strains (e,g. 0667) an additional faint band was visible between the 22Ka and b bands. In separate Western blots this proved to bear the 3H10 P epitope. All but two of the virus strains tested produced one of the four combinations of MAb reactivity pattern and P protein mobility previously recognized ( Table 2 ). The 2480 isolate made in 1966 resembled the 2825 isolate which had reactivity pattern 1 and a 34K P protein and was also isolated in that year but possessed a smaller 22K protein lacking a 1C1 epitope. The P protein also appeared to be slightly smaller. The 3862 isolate made in 1977 lacked the G 1C2 epitope but otherwise resembled viruses with reactivity pattern 2.
Reactivity of RS virus strains isolated in Newcastle with monoclonal antibodies
(a) A further seven isolates from the 1983 to 1984 epidemic, three from the 1984 to 1985 epidemic and 11 from the 1985 to 1986 epidemic were tested against the same five MAbs. The data on all virus isolates tested are summarized in Table 3 . Since 1980 viruses with reactivity pattern 2 and a Mr 34000 P protein, probably corresponding to subgroup A, have co-circulated with viruses of reactivity pattern 3 with a Mr 33000 P protein, i.e. putative subgroup B strains. Although subgroup A predominated among strains isolated in 1983 to 1984 and 1985 to 1986, in 1984 to 1985 the majority of isolates were of subgroup B.
For both subgroups the predominant strains in recent epidemics differ from prototype strains either in MAb reactivity (subgroup A) or P protein mobility (subgroup B). The prototype strains were all isolated before 1965 and it may be significant that the earliest isolate from Newcastle, made in the 1965 to 1966 epidemic, resembled the subgroup B 8/60 prototype with reactivity pattern 3 and a M r 31000 P protein (9650). In the subsequent 14 years to 1980, isolations of 33K  4K  4K  4K  ~4K  4K  4K  4K  3K  4K  33K  34K  33K  34K  33K  34K  33K putative subgroup B strains were made only in the two epidemics between 1974 and 1976 and both strains isolated possessed a M~ 33 000 P protein, unlike the earlier isolates but similar to the strains isolated in the 1980s. In the 1966 to 1967 epidemic two subgroup A strains were isolated, one with reactivity pattern 1 (2825) resembling the prototypes and the second with reactivity pattern 2 (3591) resembling those strains most frequently isolated in later years. Viruses resembling the prototype subgroup A strains with reactivity pattern 1 were isolated subsequently although only twice, in 1972 and as late as 1984, suggesting that viruses with MAb reactivity pattern 1 persist in the subgroup A population at low levels.
DISCUSSION
Our initial analysis with a small panel of subgroup-specific MAbs raised against the subgroup A A2 strain of RS virus allowed us to recognize only a minority of virus isolates circulating in Newcastle. The majority of virus isolates which did not react were found to be heterogeneous in the M~ of both the P protein and the b form of the 22K protein, suggesting that we had not achieved the clear division of isolates into two subgroups previously reported (Norrby et al., 1986) . As the two subgroups of RS virus have been shown previously to differ in the mobility of their P proteins (Cash et al., 1977; Gimenez et al., 1986) , we raised a MAb to the G protein of an isolate non-reactive with A2 MAbs but bearing a P and 22K protein with the same mobility as the A2 strain. This MAb, 1C2, proved reactive with all virus isolates, made over a 20 year period, that possessed a 34K P protein. It is likely that these viruses belong to the virus subgroup A described by Mufson et al. (1985) . Akerlind & Norrby (1986) have previously reported three subgroup A isolates which failed to react with the 1C1 MAb.
Virus isolates allocated to this subgroup are thus heterogeneous in their MAb reactivity with recently isolated strains lacking epitopes present on the prototypes. The question arises as to whether the observed variation constitutes antigenic drift from the early prototype strains, is random and non-cumulative or represents a stable polymorphism of some epitopes in the RS virus population. The answer to this question may have some bearing upon vaccine strategy. Strains resembling the prototypes and bearing the 3F4 G protein epitope and the 1C1 22K protein epitope have been isolated in Newcastle on three occasions in 1966, 1972 and 1984. There is no evidence that the differences between these strains and the more prevalent MAb reactivity 2 subgroup A strains, which lack these epitopes, have arisen in a progressive, cumulative manner representing antigenic drift. The coordinated occurrence of these two epitopes in strains isolated only occasionally and at such infrequent intervals is also difficult to explain on the basis of random mutation.
How the prototype-like strains persist in the population remains to be determined. Such viruses could occasionally spread to the human population from an animal reservoir. RS virus does infect some agricultural livestock (Stott & Taylor, 1985) and neutralizing antibody has been reported in cats (Pringle & Cross, 1978) . We have failed to confirm this observation and have found no trace of neutralizing antibody to RS virus in Newcastle cats. Furthermore, we have failed to find evidence of infection in domestic kittens after intranasal instillation of human RS virus. No virus was recovered and no seroconversion demonstrated (unpublished data). Alternatively, several variants of RS virus subgroup A may co-circulate within the human population. As all the isolates tested here came from infants in hospital, they may not be representative of the viruses circulating in the community as a whole.
The remaining isolates which failed to react with subgroup A-specific MAbs remained heterogeneous with regard to the size of the P protein but not the b form of the 22K protein which in all cases was slightly larger than that of subgroup A viruses. Norrby et al. (1986) also observed heterogeneity in the 22K protein in radioimmune precipitation assays but differences appeared to be strain-rather than subgroup-specific. This apparent discrepancy may result from the different techniques involved.
Despite the variations in the molecular weight of the P protein it is likely that these viruses represent the B subgroup (Mufson et al., 1985) and it is noteworthy in this regard that viruses with a Mr 33000 P protein were isolated from the same epidemic as subgroup A viruses in 1975 to 1976 and most strikingly in recent epidemics. None of the isolates since 1965 analysed here has possessed a Mr 31000 P protein. That viruses of this type did not die out in the 1960s is indicated by the report of Gimenez et al. (1986) that the subgroup B strain RSN-1599, originally isolated in Newcastle in 1975, possesses a low Mr P protein.
The picture in Newcastle thus resembles that elsewhere with the two virus subgroups cocirculating in recent years (Hendry et al., 1986a; Akerlind & Norrby, 1986; Gimenez et al., 1986 ). However, in this study, between 1966 and 1974 and between 1976 and 1980 no subgroup B viruses were isolated, although in previous studies B strains were isolated in 1972 (the RSN-2 strain) and 1978 (the RSN-7463 strain) (Gimenez et al., 1986) . As subgroup B viruses tend to replicate slowly in cell cultures, it is not clear whether they were less prevalent in the community during these periods or just more difficult to isolate. Their predominance in the Newcastle 1984 to 1985 epidemic suggests that when present they are detected and we thus conclude that subgroup B strains are less frequenctly associated with disease in infants overall although they may predominate in some epidemics. It is possible that the 1974 to 1976 epidemics resembled the 1984 to 1986 period with a high incidence of lower respiratory tract disease in infants due to subgroup B infections. More intensive studies of these epidemics is in progress.
These results and those of others may indicate fundamental differences in epidemiology between the two virus subgroups. It remains to be established whether there is any periodicity in the prevalence of subgroup B epidemics and whether the relative incidence of the two subgroups is determined locally or by factors with a wider influence. Further studies are also necessary to investigate whether differences in epidemiology are paralleled by differences in pathogenesis and how the two strains interact to produce the complex pattern of infection and immunity to RS virus in human infants.
